Verified email-pattern data for Enpresso Gmbh is currently limited. You can still use the company insights and contact sections below.
We offer fed-batch technology for high protein yield and biomass concentration by using media tablets and a drop of enzyme.
Enpresso utilizes its unique EnBase® technology platform to develop innovative, enzyme-based EnPresso® growth systems. We are the first company which makes it easy for every scientist to take advantage of the fed-batch cultivation by using advanced microbial cultivation media in small scale, like microwell plates and shake flasks or small bioreactors. EnPresso® growth systems are appreciated by scientists working with recombinant protein expression in academic research groups, pharmaceutical industries, or educational institutions.
„You are what you eat” applies not only to humans, but also to microorganisms 😊
Keeping the carbon source, such as glucose, as a limiting factor in biotechnology processes is called fed-batch strategy. Similar as a pump speed, the feed solution controls the cell growth in bioreactors - the amount of added enzyme controls the glucose release from a metabolically inactive polymer and thereby the cell growth in EnPresso® growth systems.
This patented innovation made fed-batch technology applicable across all lab scales.
Enpresso GmbH develops fully dissolvable ready-to-use media tablets
• to promote microbial cell growth
• to support a stable pH
• to regulate glucose availability for significantly higher cell densities and
• to increase product yields.
EnPresso® growth systems create optimal metabolic conditions thereby reducing the risk of incorrect protein folding and increasing the percentage of soluble protein.
We believe that our Enpresso® products will be of great benefit to everyone working with recombinant protein expression in bacteria and yeast, as the advantages of ease of use and good results are convincing.
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- Website
- http://www.enpresso.de
- Keywords
- Advanced ready-to-use cultivation media; controlled glucose-release; fed-batch technology; bacterial cultivation; yeast cultivation; scalable microbial cultivation; repeatable parallel cultivation; high protein yield, recombinant protein production; continuous defined fed-batch in small-scale cultivations; carbon-limited; scale-down; high-throughput bioprocess development.
Enpresso Gmbh Questions
Enpresso GmbH's website is http://www.enpresso.de
Enpresso GmbH's LinkedIn profile is https://www.linkedin.com/company/enpresso
Enpresso GmbH has
2 employees.
View email and phone details for 2
employees at Enpresso GmbH.
Enpresso GmbH's industry is
Biotechnology Research
Enpresso GmbH's top competitors are
Animox Gmbh,
Bionukleo,
Bovogen Biologicals Pty Ltd.,
Bio-Pat E.v.,
Cell4chem,
Korsch Ag,
Bioprocess Engineering-Tu Berlin,
Kiwi-Biolab,
Biosilta,
Probiogen Ag.
Enpresso GmbH's categories are Biotechnology Research
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.